Santi Daniele, Spaggiari Giorgia, Casarini Livio, Fanelli Flaminia, Mezzullo Marco, Pagotto Uberto, Granata Antonio R M, Carani Cesare, Simoni Manuela
a Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia , Modena , Italy.
b Unit of Endocrinology, Department of Medicine, Endocrinology, Metabolism and Geriatrics, Azienda USL of Modena , Modena , Italy.
Aging Male. 2017 Jun;20(2):96-101. doi: 10.1080/13685538.2016.1276161. Epub 2017 Jan 9.
We present a case report of an atypical giant pituitary adenoma secreting follicle-stimulating hormone (FSH). A 55-year-old patient presented for erectile dysfunction, loss of libido and fatigue. The biochemical evaluation showed very high FSH serum levels in the presence of central hypogonadism. Neither testicular enlargement nor increased sperm count was observed, thus a secretion of FSH with reduced biological activity was supposed. The histological examination after neuro-surgery showed an atypical pituitary adenoma with FSH-positive cells. Hypogonadism persisted and semen analyses impaired until azoospermia in conjunction with the reduction in FSH levels suggesting that, at least in part, this gonadotropin should be biologically active. Thus, we hypothesized a concomitant primary testicular insufficiency. The patient underwent short-term treatment trials with low doses of either recombinant luteinizing hormone (LH) or human chorionic gonadotropin (hCG) in three consecutive treatment schemes, showing an equal efficacy in stimulating testosterone (T) increase. This is the first case of atypical, giant FSH-secreting pituitary adenoma with high FSH serum levels without signs of testicular hyperstimulation, in presence of hypogonadism with plausible combined primary and secondary etiology. Hypophysectomized patients may represent a good model to assess both pharmacodynamics and effective dose of LH and hCG in the male.
我们报告一例分泌促卵泡生成素(FSH)的非典型巨大垂体腺瘤病例。一名55岁患者因勃起功能障碍、性欲减退和疲劳前来就诊。生化评估显示,在存在中枢性性腺功能减退的情况下,血清FSH水平非常高。未观察到睾丸增大或精子计数增加,因此推测分泌的FSH生物活性降低。神经外科手术后的组织学检查显示为非典型垂体腺瘤,FSH阳性细胞。性腺功能减退持续存在,精液分析受损,直至无精子症,同时FSH水平降低,这表明至少部分这种促性腺激素应具有生物活性。因此,我们推测同时存在原发性睾丸功能不全。患者在三个连续的治疗方案中接受了低剂量重组促黄体生成素(LH)或人绒毛膜促性腺激素(hCG)的短期治疗试验,结果显示在刺激睾酮(T)升高方面疗效相同。这是首例非典型、巨大的分泌FSH的垂体腺瘤,血清FSH水平高,无睾丸过度刺激迹象,存在性腺功能减退,病因可能为原发性和继发性合并。垂体切除患者可能是评估LH和hCG在男性体内的药效学和有效剂量的良好模型。